Related references
Note: Only part of the references are listed.Intracranial AAV-sTRAIL combined with lanatoside C prolongs survival in an orthotopic xenograft mouse model of invasive glioblastoma
Matheus H. W. Crommentuijn et al.
MOLECULAR ONCOLOGY (2016)
Targeting transgene to the heart and liver with AAV9 by different promoters
Bang-Dang Chen et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2015)
Interferon-β Modulates the Innate Immune Response against Glioblastoma Initiating Cells
Fabian Wolpert et al.
PLOS ONE (2015)
Identification of OLIG2 as the most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platforms
Anne-Laure Trepant et al.
TUMOR BIOLOGY (2015)
Interferon-Stimulated Genes: A Complex Web of Host Defenses
William M. Schneider et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Targeting the Tumor Microenvironment with Interferon-β Bridges Innate and Adaptive Immune Responses
Xuanming Yang et al.
CANCER CELL (2014)
Bridging the Species Divide: Transgenic Mice Humanized for Type-I Interferon Response
Daniel Harari et al.
PLOS ONE (2014)
Identification of Molecular Pathways Facilitating Glioma Cell Invasion In Situ
Ido Nevo et al.
PLOS ONE (2014)
Human thyroxine binding globulin (TBG) promoter directs efficient and sustaining transgene expression in liver-specific pattern
Zhonghai Yan et al.
GENE (2012)
Interferon-β efficiently inhibited endothelial progenitor cell-induced tumor angiogenesis
H-B Xiao et al.
GENE THERAPY (2012)
Current Concepts and Management of Glioblastoma
Matthias Preusser et al.
ANNALS OF NEUROLOGY (2011)
Benefits of Interferon-β and Temozolomide Combination Therapy for Newly Diagnosed Primary Glioblastoma With the Unmethylated MGMT Promoter A Multicenter Study
Kazuya Motomura et al.
CANCER (2011)
Synergistic tumor cell killing with ganciclovir and vorinostat is due to inhibition of homologous recombination
Brendon Ladd et al.
CANCER RESEARCH (2011)
MicroRNA-regulated, Systemically Delivered rAAV9: A Step Closer to CNS-restricted Transgene Expression
Jun Xie et al.
MOLECULAR THERAPY (2011)
Systemic Gene Delivery in Large Species for Targeting Spinal Cord, Brain, and Peripheral Tissues for Pediatric Disorders
Adam K. Bevan et al.
MOLECULAR THERAPY (2011)
microRNA-451 A conditional switch controlling glioma cell proliferation and migration
Jakub Godlewski et al.
CELL CYCLE (2010)
High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency
E. Ayuso et al.
GENE THERAPY (2010)
Human Glioblastoma-Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
Hiroaki Wakimoto et al.
CANCER RESEARCH (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons
Sandra Duque et al.
MOLECULAR THERAPY (2009)
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
Kevin D. Foust et al.
NATURE BIOTECHNOLOGY (2009)
Preventing growth of brain tumors by creating a zone of resistance
Casey A. Maguire et al.
MOLECULAR THERAPY (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Antitumor efficacy of AAV-mediated systemic delivery of interferon-beta
CJ Streck et al.
CANCER GENE THERAPY (2006)
Interferon-mediated anti-angiogenic therapy for neuroblastoma
CJ Streck et al.
CANCER LETTERS (2005)
The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas
KL Ligon et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
IFN-β induces caspase-mediated apoptosis by disrupting mitochondria in human advanced stage colon cancer cell lines
SH Juang et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2004)
Direct evidence that IFN-β functions as a tumor-suppressor protein
C Kaynor et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2002)
Human and mouse IFN-β gene therapy exhibits different anti-tumor mechanisms in mouse models
XQ Qin et al.
MOLECULAR THERAPY (2001)
Pharmacokinetics and pharmacodynamics of IFN-β1a in healthy volunteers
PA Buchwalder et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2000)
Share Paper
